Publications in collaboration with researchers from Cardiff University (20)

2024

  1. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease

    Nature Genetics, Vol. 56, Núm. 1, pp. 27-36

2023

  1. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinson's Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)

    npj Parkinson's Disease

  2. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

    npj Parkinson's Disease, Vol. 9, Núm. 1

2021

  1. F36 DXA, BIA, anthropometry and skin folds methodology in body composition

    Journal of Neurology, Neurosurgery & Psychiatry: EHDNAbstracts 2021, Vol. 92, Núm. Suppl 1

2019

  1. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

2018

  1. Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life

    Movement Disorders, Vol. 33, Núm. 5, pp. 742-749

  2. Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations

    Movement Disorders Clinical Practice, Vol. 5, Núm. 4, pp. 361-372

  3. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

    Journal of Huntington's Disease, Vol. 7, Núm. 3, pp. 209-222

2017

  1. Cognitive decline in Huntington's disease expansion gene carriers

    Cortex, Vol. 95, pp. 51-62

  2. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

    The Lancet Neurology, Vol. 16, Núm. 9, pp. 701-711

  3. Interstrand DNA covalent binding of two dinuclear Ru(ii) complexes. Influence of the extra ring of the bridging ligand on the DNA interaction and cytotoxic activity

    Dalton Transactions, Vol. 46, Núm. 11, pp. 3611-3622

  4. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Nature Genetics, Vol. 49, Núm. 9, pp. 1373-1384

  5. Response to letter by Saenz-Farret et al. on “Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations”

    Movement Disorders

2016

  1. A novel Alzheimer disease locus located near the gene encoding tau protein

    Molecular Psychiatry, Vol. 21, Núm. 1, pp. 108-117

  2. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases

    Neurobiology of Aging, Vol. 38, pp. 214.e7-214.e10

  3. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations

    Movement Disorders, Vol. 31, Núm. 10, pp. 1466-1478

2015

  1. Stabilization of Al(III) solutions by complexation with cacodylic acid: Speciation and binding features

    Physical Chemistry Chemical Physics, Vol. 17, Núm. 44, pp. 29803-29813

2014

  1. Frontotemporal dementia and its subtypes: A genome-wide association study

    The Lancet Neurology, Vol. 13, Núm. 7, pp. 686-699

2013

  1. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

  2. The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients

    PLoS ONE, Vol. 8, Núm. 7